Proactive patients in reviewing select health information and issues 2013
This statistic displays the percentage of patients who believe that they are proactive in reviewing information on certain health issues in 2014. In that year, 75 percent of people taking long-term medication described themselves as proactive in reviewing information on chronic conditions. Many believe its important to have complementary services to pharmaceutical products.
Patients describing themselves as proactive
About 80 percent of patients currently taking medication often refer to themselves as proactive in reviewing information about medication, while only 65 percent say they actively review information on certain illnesses or ailments. Many pharmaceutical companies provide certain services for their patients such as product information or nurse support via the phone, along with their medications. Patients that receive these types of services often appreciate their value and often feel that these services could be received via digital or online channels.
Product information on medication is one of the most commonly received services, with 48 percent of users obtaining this information. A rewards program is desired by about 63 percent of patients in the United States but only 10 percent receive this option. Financial assistance is also rated as one of the most important services, with about 64 percent of patients listing it as part of their top five services. Many patients are willing to collaborate with pharmaceutical companies to receive certain services. These firms can use patient services to help launch new products or initiate payer programs for patients and retailers for better service. The healthcare and pharmaceutical industries in the United States spent 1.02 billion U.S. dollars in 2011 on digital advertising and is expected to spend upwards of 2.22 billion U.S. dollars by 2018.
Patients describing themselves as proactive
About 80 percent of patients currently taking medication often refer to themselves as proactive in reviewing information about medication, while only 65 percent say they actively review information on certain illnesses or ailments. Many pharmaceutical companies provide certain services for their patients such as product information or nurse support via the phone, along with their medications. Patients that receive these types of services often appreciate their value and often feel that these services could be received via digital or online channels.
Product information on medication is one of the most commonly received services, with 48 percent of users obtaining this information. A rewards program is desired by about 63 percent of patients in the United States but only 10 percent receive this option. Financial assistance is also rated as one of the most important services, with about 64 percent of patients listing it as part of their top five services. Many patients are willing to collaborate with pharmaceutical companies to receive certain services. These firms can use patient services to help launch new products or initiate payer programs for patients and retailers for better service. The healthcare and pharmaceutical industries in the United States spent 1.02 billion U.S. dollars in 2011 on digital advertising and is expected to spend upwards of 2.22 billion U.S. dollars by 2018.
